健帆生物(300529.SZ):監事會主席彭小紅的子女彭程程短線交易
格隆匯5月20日丨健帆生物(300529.SZ)公佈,公司監事會主席彭小紅的子女彭程程於2021年4月22日至2021年5月13日期間買賣公司股票,導致構成短線交易行為。根據《證券法》《深圳證券交易所創業板上市公司規範運作指引》等相關法律法規的規定,現將有關情況公吿如下:

上述交易行為違反了《中華人民共和國證券法》、《深圳證券交易所上市公司規範運作指引》等相關規定,構成短線交易行為。經核查,彭程程此次短線交易為其個人不熟悉相關法律法規導致的操作,不存在因獲悉內幕信息而交易公司股票謀求利益的情形。截至公吿披露日,彭程程持有公司股票0股。
彭程程此次短線交易產生的收益為:賣出價格*賣出股數-買入價格*買入股數-手續費-印花税+股息紅利(税後)=99元/股*7125股-36.41元/股*7125股-141.08元-705.38元+(4702.50元-940.50元)=448,869.29元。
上述所得收益448,869.29元作為此次短線交易的獲利金額已及時全數上交公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.